Clinical Trial Update: CNS10-NPC for the Treatment of RP [Phase 1]

View source ↗

Summary

A Phase 1 study evaluating CNS10-NPC for the treatment of retinitis pigmentosa, with the trial status listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Retinitis Pigmentosa

Drugs mentioned

• CNS10-NPC

Snippet

Sponsor: Cedars-Sinai Medical Center | Conditions: Retinitis Pigmentosa | Phase 1 | Status: ACTIVE_NOT_RECRUITING